These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 31362307)

  • 1. Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 years: a nationwide population-based cohort study in France.
    Giral P; Neumann A; Weill A; Coste J
    Eur Heart J; 2019 Nov; 40(43):3516-3525. PubMed ID: 31362307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins for primary prevention and rhabdomyolysis: A nationwide cohort study in France.
    Coste J; Billionnet C; Rudnichi A; Pouchot J; Dray-Spira R; Giral P; Zureik M
    Eur J Prev Cardiol; 2019 Mar; 26(5):512-521. PubMed ID: 29799296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin Discontinuation and Cardiovascular Events Among Older People in Denmark.
    Thompson W; Morin L; Jarbøl DE; Andersen JH; Ernst MT; Nielsen JB; Haastrup P; Schmidt M; Pottegård A
    JAMA Netw Open; 2021 Dec; 4(12):e2136802. PubMed ID: 34854906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discontinuing statins or not in the elderly? Study protocol for a randomized controlled trial.
    Bonnet F; Bénard A; Poulizac P; Afonso M; Maillard A; Salvo F; Berdaï D; Salles N; Rousselot N; Marchi S; Hayes N; Joseph JP
    Trials; 2020 Apr; 21(1):342. PubMed ID: 32307005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of a public media event on the use of statins in the French population.
    Bezin J; Francis F; Nguyen NV; Robinson P; Blin P; Fourrier-Réglat A; Pariente A; Moore N
    Arch Cardiovasc Dis; 2017 Feb; 110(2):91-98. PubMed ID: 27473579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database.
    Vinogradova Y; Coupland C; Brindle P; Hippisley-Cox J
    BMJ; 2016 Jun; 353():i3305. PubMed ID: 27353261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A risk stratification analysis of atherosclerotic cardiovascular disease events post-statin discontinuation in patients who underwent sleeve gastrectomy or Roux-en-Y gastric bypass bariatric/metabolic surgeries.
    Alsuhibani AA; Al-Kadi A; Wigle PR; Guo JJ; Lin AC; Rao MB; Hincapie AL
    Surgery; 2024 Sep; 176(3):597-604. PubMed ID: 38902126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Events After Discontinuation of β-Blockers in Patients Without Heart Failure Optimally Treated After Acute Myocardial Infarction: A Cohort Study on the French Healthcare Databases.
    Neumann A; Maura G; Weill A; Alla F; Danchin N
    Circ Cardiovasc Qual Outcomes; 2018 Apr; 11(4):e004356. PubMed ID: 29653999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins for primary prevention of cardiovascular disease and the risk of acute kidney injury.
    Coste J; Karras A; Rudnichi A; Dray-Spira R; Pouchot J; Giral P; Zureik M
    Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1583-1590. PubMed ID: 31517431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins for primary prevention in adults aged 75 years and older: A nationwide population-based case-control study.
    Jun JE; Cho IJ; Han K; Jeong IK; Ahn KJ; Chung HY; Hwang YC
    Atherosclerosis; 2019 Apr; 283():28-34. PubMed ID: 30772771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inception and deprescribing of statins in people aged over 80 years: cohort study.
    Gulliford M; Ravindrarajah R; Hamada S; Jackson S; Charlton J
    Age Ageing; 2017 Nov; 46(6):1001-1005. PubMed ID: 29088364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in preventing new-onset cardiovascular events with statin therapy in seniors aged 75 years and over: A cohort study in the South Korean National Health Insurance Database.
    Kim K; Kwak A; Choi CU; Kim JH; Kim MG; Oh JM; Ji E
    Basic Clin Pharmacol Toxicol; 2019 Aug; 125(2):108-116. PubMed ID: 30924261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in Statin Prescription Patterns in Patients Admitted to an Australian Geriatric Subacute Unit.
    Noaman S; Al-Mukhtar O; Abramovic S; Mohammed H; Goh CY; Long C; Neil C; Janus E; Cox N; Chan W
    Heart Lung Circ; 2019 Mar; 28(3):423-429. PubMed ID: 29433992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin adherence is lower in primary than secondary prevention: A national follow-up study of new users.
    Sigglekow F; Horsburgh S; Parkin L
    PLoS One; 2020; 15(11):e0242424. PubMed ID: 33211724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial.
    Kutner JS; Blatchford PJ; Taylor DH; Ritchie CS; Bull JH; Fairclough DL; Hanson LC; LeBlanc TW; Samsa GP; Wolf S; Aziz NM; Currow DC; Ferrell B; Wagner-Johnston N; Zafar SY; Cleary JF; Dev S; Goode PS; Kamal AH; Kassner C; Kvale EA; McCallum JG; Ogunseitan AB; Pantilat SZ; Portenoy RK; Prince-Paul M; Sloan JA; Swetz KM; Von Gunten CF; Abernethy AP
    JAMA Intern Med; 2015 May; 175(5):691-700. PubMed ID: 25798575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Statin Adherence on Cardiovascular Morbidity and All-Cause Mortality in the Primary Prevention of Cardiovascular Disease: A Population-Based Cohort Study in Finland.
    Rannanheimo PK; Tiittanen P; Hartikainen J; Helin-Salmivaara A; Huupponen R; Vahtera J; Korhonen MJ
    Value Health; 2015 Sep; 18(6):896-905. PubMed ID: 26409618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence With Statins in Primary Prevention of Cardiovascular Disease: Findings From a Cohort of Spanish Workers.
    Malo S; Aguilar-Palacio I; Feja C; Menditto E; Lallana MJ; Andrade E; Casasnovas JA; Rabanaque MJ
    Rev Esp Cardiol (Engl Ed); 2018 Jan; 71(1):26-32. PubMed ID: 28473266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin adherence and risk of acute cardiovascular events among women: a cohort study accounting for time-dependent confounding affected by previous adherence.
    Lavikainen P; Helin-Salmivaara A; Eerola M; Fang G; Hartikainen J; Huupponen R; Korhonen MJ
    BMJ Open; 2016 Jun; 6(6):e011306. PubMed ID: 27259530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of statin discontinuation and restarting rates on the optimal time to initiate statins and on the number of cardiovascular events prevented.
    Pate A; Elliott RA; Gkountouras G; Thompson A; Emsley R; van Staa T
    Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):644-652. PubMed ID: 32394495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, Associated Risk Factors, and Adverse Cardiovascular Outcomes of Statins Discontinuation: A Systematic Review.
    Ageeb SA; Abdelmoghith A; ElGeed H; Awaisu A; ElMansor A; Owusu YB
    Pharmacoepidemiol Drug Saf; 2024 Aug; 33(8):e5879. PubMed ID: 39135516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.